TrialReader


Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

NCT06348186 — Not applicable, Unknown, 30 participants, University of the State of Santa Catarina

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT06348186
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment30 (Estimated)
SponsorUniversity of the State of Santa Catarina (Other); collaborators: Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
ConditionsCOVID-19
InterventionsGuidebook, Guidebook and Myofascial Reorganization® (RMF). (Other)
Datesstart 2024-02-01, primary completion 2024-04-01, completion 2025-08-31 (estimated), first posted 2024-04-04, last updated 2024-11-20
Locations1 site in Brazil

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for COVID-19 All trials of Guidebook All trials of Guidebook and Myofascial Reorganization® (RMF).

-Summary

According to the World Health Organization (WHO), as of mid-September 2022, more than 21 million Brazilians have recovered from COVID-19. However, post-infection symptoms continue to appear months after the end of the acute infection, a syndrome called long COVID. Therefore, the aim of this study is to investigate the responses of fascia-focused manual therapy in participants with long COVID.

Expand all sections  ·  Collapse all

+Detailed description

Participants reported to have long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals will be evaluated. The treatment of participants will be carried out at the CEFID-UDESC Physiotherapy School Clinic, where they will undergo assessment of the biomechanical and viscoelastic properties of tissues, postural control, pain and quality of life. For normality analysis, the Shapiro-Wilk test will be applied, and according to the distribution of the data, parametric or non-parametric tests will be used. Pre- and post-assessment and treatment data will be compared using descriptive statistics and Student's t-test with a significance level of p=0.05 for parametric data or Wilcoxon for non-parametric data.

+Arms and interventions

ArmTypeInterventionsDescription
GuidebookOtherOther: Guidebook
Guidebook and Myofascial Reorganization® (RMF).ExperimentalOther: Guidebook and Myofascial Reorganization® (RMF).
  • Guidebook (Other): Folder that will be given to the participant to carry out 5 minutes of intervention daily
  • Guidebook and Myofascial Reorganization® (RMF). (Other): The intervention will be carried out once a week for 30 minutes for 6 weeks. It will include passive, active-assisted moments (with and without load). In addition to a folder that will be given to the participant to carry out 5 minutes of intervention daily.

+Outcome measures

Primary outcomes

  • Functioning and disability [6 weeks]: Will be assessed using the "World Health Organization Disability Assessment" questionnaire (WHO-DAS 2.0), translated and validated for the Brazilian population by Silveira et al. (2013).
  • Biomechanical and tissue viscoelastic properties [6 weeks]: Will be evaluated by MyotonPro (MytonPro, Myoton Ltd.s., Tartu, Estonia)

Secondary outcomes

  • Work capacity [6 weeks]: Will be assessed by the "Work Limitations Questionnaire, WLQ-25" translated and validated for the Brazilian population by Soárez et al (2007).
  • Level of Quality of life [6 weeks]: Will be assessed by the "World Health Organization Questionnaire" in its short version, validated in the Brazilian population and by the "Medical Outcomes Study 36-Item Short Form Health" questionnaire Survey" validated for Brazilian-Portuguese.
  • Upper limb dysfunctions [6 weeks]: Will be assessed using the Arm, Shoulder and Hand Dysfunctions questionnaire (DASH), translated and validated for the Brazilian population by Orfale et al (2005).
  • Balance [6 weeks]: Will be assessed using the Neurocom Balance Platform (VRS Sport) and its NeuroCom®Balance Manager program (Neurocom International, Inc, Clackamas, OR).

+Eligibility

Sex: All, ages: 20 Years to 80 Years, accepts healthy volunteers

Inclusion Criteria:

* Participants diagnosed with long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals.

Exclusion Criteria:

* Participants with suspected deep vein thrombosis; Participants with neurological disorders.

+Locations (1)

FacilityCityCountryStatus
Santa Catarina State UniversityFlorianópolis, Santa CatarinaBrazilRecruiting

My Notes